Charles B Eaton1, Mary Pettinger2, Jacques Rossouw2, Lisa Warsinger Martin2, Randi Foraker2, Abdullah Quddus2, Simin Liu2, Nina S Wampler2, Wen-Chih Hank Wu2, JoAnn E Manson2, Karen Margolis2, Karen C Johnson2, Matthew Allison2, Giselle Corbie-Smith2, Wayne Rosamond2, Khadijah Breathett2, Liviu Klein2. 1. From the Center of Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket (C.B.E., A.Q.); School of Public Health, Alpert Medical School, Brown University, Providence, RI (C.B.E., S.L.); Fred Hutchinson Cancer Research Center, Seattle, WA (M.P.); Women's Health Initiative Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (J.R.); George Washington University School of Medicine and Health Sciences, Washington, DC (L.W.M.); Division of Epidemiology, College of Public Health, The Ohio State University Columbus (R.F.); The University of Arizona Cancer Center, Phoenix, AZ (N.S.W.); Providence VA Medical Center, RI (W.-C.H.W.); Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.E.M.); HealthPartners Institute for Research and Education, Minneapolis, MN (K.M.); University of Tennessee Health Science Center, Memphis, TN (K.C.J.); University of California San Diego (M.A.); The University of North Carolina, Chapel Hill (G.C.-S., W.R.); The Ohio State University Wexner Medical Center, Columbus (K.B.); The Ohio State University Davis Heart and Lung Research Institute, Columbus (K.B.); and University of California San Francisco (L.K.). charles_eaton@mhri.org. 2. From the Center of Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket (C.B.E., A.Q.); School of Public Health, Alpert Medical School, Brown University, Providence, RI (C.B.E., S.L.); Fred Hutchinson Cancer Research Center, Seattle, WA (M.P.); Women's Health Initiative Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (J.R.); George Washington University School of Medicine and Health Sciences, Washington, DC (L.W.M.); Division of Epidemiology, College of Public Health, The Ohio State University Columbus (R.F.); The University of Arizona Cancer Center, Phoenix, AZ (N.S.W.); Providence VA Medical Center, RI (W.-C.H.W.); Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.E.M.); HealthPartners Institute for Research and Education, Minneapolis, MN (K.M.); University of Tennessee Health Science Center, Memphis, TN (K.C.J.); University of California San Diego (M.A.); The University of North Carolina, Chapel Hill (G.C.-S., W.R.); The Ohio State University Wexner Medical Center, Columbus (K.B.); The Ohio State University Davis Heart and Lung Research Institute, Columbus (K.B.); and University of California San Francisco (L.K.).
Abstract
BACKGROUND: Heart failure is an important and growing public health problem in women. Risk factors for incident hospitalized heart failure with preserved ejection fraction (HFpEF) compared with heart failure with reduced ejection fraction (HFrEF) in women and differences by race/ethnicity are not well characterized. METHODS AND RESULTS: We prospectively evaluated the risk factors for incident hospitalized HFpEF and HFrEF in a multiracial cohort of 42 170 postmenopausal women followed up for a mean of 13.2 years. Cox regression models with time-dependent covariate adjustment were used to define risk factors for HFpEF and HFrEF. Differences by race/ethnicity about incidence rates, baseline risk factors, and their population-attributable risk percentage were analyzed. Risk factors for both HFpEF and HFrEF were as follows: older age, white race, diabetes mellitus, cigarette smoking, and hypertension. Obesity, history of coronary heart disease (other than myocardial infarction), anemia, atrial fibrillation, and more than one comorbidity were associated with HFpEF but not with HFrEF. History of myocardial infarction was associated with HFrEF but not with HFpEF. Obesity was found to be a more potent risk factor for African American women compared with white women for HFpEF (P for interaction=0.007). For HFpEF, the population-attributable risk percentage was greatest for hypertension (40.9%) followed by obesity (25.8%), with the highest population-attributable risk percentage found in African Americans for these risk factors. CONCLUSIONS: In this multiracial cohort of postmenopausal women, obesity stands out as a significant risk factor for HFpEF, with the strongest association in African American women. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000611.
BACKGROUND:Heart failure is an important and growing public health problem in women. Risk factors for incident hospitalized heart failure with preserved ejection fraction (HFpEF) compared with heart failure with reduced ejection fraction (HFrEF) in women and differences by race/ethnicity are not well characterized. METHODS AND RESULTS: We prospectively evaluated the risk factors for incident hospitalized HFpEF and HFrEF in a multiracial cohort of 42 170 postmenopausal women followed up for a mean of 13.2 years. Cox regression models with time-dependent covariate adjustment were used to define risk factors for HFpEF and HFrEF. Differences by race/ethnicity about incidence rates, baseline risk factors, and their population-attributable risk percentage were analyzed. Risk factors for both HFpEF and HFrEF were as follows: older age, white race, diabetes mellitus, cigarette smoking, and hypertension. Obesity, history of coronary heart disease (other than myocardial infarction), anemia, atrial fibrillation, and more than one comorbidity were associated with HFpEF but not with HFrEF. History of myocardial infarction was associated with HFrEF but not with HFpEF. Obesity was found to be a more potent risk factor for African American women compared with white women for HFpEF (P for interaction=0.007). For HFpEF, the population-attributable risk percentage was greatest for hypertension (40.9%) followed by obesity (25.8%), with the highest population-attributable risk percentage found in African Americans for these risk factors. CONCLUSIONS: In this multiracial cohort of postmenopausal women, obesity stands out as a significant risk factor for HFpEF, with the strongest association in African American women. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000611.
Authors: Frank P Brouwers; Rudolf A de Boer; Pim van der Harst; Adriaan A Voors; Ron T Gansevoort; Stephan J Bakker; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst Journal: Eur Heart J Date: 2013-03-06 Impact factor: 29.983
Authors: R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard Journal: Am J Cardiol Date: 2000-11-15 Impact factor: 2.778
Authors: D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright Journal: Am J Cardiol Date: 2001-02-15 Impact factor: 2.778
Authors: Charles B Eaton; Abdulrahman M Abdulbaki; Karen L Margolis; Joann E Manson; Marian Limacher; Liviu Klein; Matthew A Allison; Jennifer G Robinson; J David Curb; Lisa A Martin; Simin Liu; Barbara V Howard Journal: Circulation Date: 2012-07-02 Impact factor: 29.690
Authors: Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima Journal: Arch Intern Med Date: 2008-10-27
Authors: Carolyn S P Lam; Peter E Carson; Inder S Anand; Thomas S Rector; Michael Kuskowski; Michel Komajda; Robert S McKelvie; John J McMurray; Michael R Zile; Barry M Massie; Dalane W Kitzman Journal: Circ Heart Fail Date: 2012-08-10 Impact factor: 8.790
Authors: Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon Journal: JACC Heart Fail Date: 2013-04 Impact factor: 12.035
Authors: Patricia P Chang; Lloyd E Chambless; Eyal Shahar; Alain G Bertoni; Stuart D Russell; Hanyu Ni; Max He; Thomas H Mosley; Lynne E Wagenknecht; Tandaw E Samdarshi; Lisa M Wruck; Wayne D Rosamond Journal: Am J Cardiol Date: 2013-11-09 Impact factor: 2.778
Authors: Whitney E Hornsby; Mohamed-Ali Sareini; Jessica R Golbus; Cristen J Willer; Jennifer L McNamara; Matthew C Konerman; Scott L Hummel Journal: J Card Fail Date: 2018-09-13 Impact factor: 5.712
Authors: Emily S Lau; Samantha M Paniagua; James Sawalla Guseh; Vijeta Bhambhani; Markella V Zanni; Paul Courchesne; Asya Lyass; Martin G Larson; Daniel Levy; Jennifer E Ho Journal: J Am Coll Cardiol Date: 2019-09-24 Impact factor: 24.094
Authors: Maria L Loredo-Mendoza; Israel Ramirez-Sanchez; Moises Muratt Bustamante-Pozo; Marcos Ayala; Viridiana Navarrete; Alejandra Garate-Carrillo; Bruce R Ito; Guillermo Ceballos; Jeffrey Omens; Francisco Villarreal Journal: Exp Biol Med (Maywood) Date: 2020-03-17
Authors: Michael J LaMonte; Joseph C Larson; JoAnn E Manson; John Bellettiere; Cora E Lewis; Andrea Z LaCroix; Jennifer W Bea; Karen C Johnson; Liviu Klein; Corinna A Noel; Marcia L Stefanick; Jean Wactawski-Wende; Charles B Eaton Journal: Circ Heart Fail Date: 2020-11-24 Impact factor: 8.790
Authors: Vishal N Rao; Di Zhao; Matthew A Allison; Eliseo Guallar; Kavita Sharma; Michael H Criqui; Mary Cushman; Roger S Blumenthal; Erin D Michos Journal: JACC Heart Fail Date: 2018-10-10 Impact factor: 12.035
Authors: Daisuke Kamimura; Loretta R Cain; Robert J Mentz; Wendy B White; Michael J Blaha; Andrew P DeFilippis; Ervin R Fox; Carlos J Rodriguez; Rachel J Keith; Emelia J Benjamin; Javed Butler; Aruni Bhatnagar; Rose M Robertson; Michael D Winniford; Adolfo Correa; Michael E Hall Journal: Circulation Date: 2018-04-16 Impact factor: 29.690
Authors: Boback Ziaeian; Gerald F Kominski; Michael K Ong; Vickie M Mays; Robert H Brook; Gregg C Fonarow Journal: Circ Cardiovasc Qual Outcomes Date: 2017-07
Authors: Nora Franceschini; Jeffrey B Kopp; Ana Barac; Lisa W Martin; Yun Li; Huijun Qian; Alex P Reiner; Martin Pollak; Robert B Wallace; Wayne D Rosamond; Cheryl A Winkler Journal: JAMA Cardiol Date: 2018-08-01 Impact factor: 14.676